Status:

RECRUITING

Evaluation of the Antioxidant and Anti-Inflammatory Capacities of the 'Rosy Red Valencia' and 'Olinda Valencia' Sweet Orange Varieties in Healthy Subjects

Lead Sponsor:

University of California, Davis

Conditions:

Healthy

Eligibility:

All Genders

25-40 years

Phase:

NA

Brief Summary

This study aims to evaluate the antioxidant and anti-inflammatory effects of acute and chronic consumption of two sweet orange (Citrus sinensis) varieties-'Rosy Red Valencia', which is rich in caroten...

Detailed Description

The health benefits of orange consumption have been described; however, the specific bioactive compounds responsible for these effects, as well as the underlying mechanisms of action, are not fully un...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Healthy men and women
  • Age Range: 25-40 years
  • Body mass index (BMI) with values between 21 and 29.9 kg\^m2
  • Willingness to accept randomization, undergo the testing and intervention procedures, and deliver blood and stool samples
  • Willingness to refrain from consuming foods rich in lycopene, phytoene, and phytofluene and limit the intake of some polyphenol-rich foods
  • Willingness to discontinue the use of antioxidant supplements (such as carotenoid, polyphenol supplements), prebiotics and/or probiotics
  • Exclusion Criteria:
  • Pregnancy/lactation
  • History of cardiovascular diseases, diabetes, uncontrolled hypertension, heart failure, stroke, liver, gallbladder, kidney, thyroid disease, gastrointestinal, autoimmune disorder, or cancer.
  • Psychiatric disease that interferes with the understanding and implementation of the intervention
  • History of eating disorders (such as bulimia nervosa and anorexia nervosa) in the last 5 years
  • Current smokers
  • Vegan, vegetarian, or other special diets (e.g., keto, paleo)
  • Use of antibiotics or laxatives in the previous month
  • History of substance abuse or alcohol abuse
  • involvement in a weight loss intervention program within the past month or weight change \> 10%
  • Self-report of allergic reactions to study products or their phytochemicals.

Exclusion

    Key Trial Info

    Start Date :

    April 17 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 30 2026

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT06944210

    Start Date

    April 17 2025

    End Date

    January 30 2026

    Last Update

    April 25 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Nutrition Department, Ragle Facility, University of California Davis

    Davis, California, United States, 95616